NAPA, Calif.--(BUSINESS WIRE)--Asphelia Pharmaceuticals, a privately-held, clinical-stage company focused on the development of novel therapeutics for the treatment of a variety of immunological disorders, will be presenting at this year’s tenth annual C21 BioVentures Conference in Napa, CA. C21 is a private lifescience company conference aimed at fostering relationships within the biotechnology, pharmaceutical, and venture capital industries. This year’s C21 will be held at The Meritage Resort at Napa from May 20th to May 22nd.
